378 related articles for article (PubMed ID: 23866813)
1. A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
Kean JD; Camfield D; Sarris J; Kras M; Silberstein R; Scholey A; Stough C
Nutr J; 2013 Jul; 12():100. PubMed ID: 23866813
[TBL] [Abstract][Full Text] [Related]
2. Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial.
Kean JD; Sarris J; Scholey A; Silberstein R; Downey LA; Stough C
Psychopharmacology (Berl); 2017 Feb; 234(3):403-420. PubMed ID: 27921139
[TBL] [Abstract][Full Text] [Related]
3. Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial.
Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
J Atten Disord; 2015 Nov; 19(11):954-64. PubMed ID: 24214970
[TBL] [Abstract][Full Text] [Related]
4. Marine lipid fraction PCSO-524 (lyprinol/omega XL) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma.
Mickleborough TD; Vaughn CL; Shei RJ; Davis EM; Wilhite DP
Respir Med; 2013 Aug; 107(8):1152-63. PubMed ID: 23660397
[TBL] [Abstract][Full Text] [Related]
5. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
[TBL] [Abstract][Full Text] [Related]
6. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.
Crippa A; Tesei A; Sangiorgio F; Salandi A; Trabattoni S; Grazioli S; Agostoni C; Molteni M; Nobile M
Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):571-583. PubMed ID: 30246216
[TBL] [Abstract][Full Text] [Related]
9. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
[TBL] [Abstract][Full Text] [Related]
10. The effects PCSO-524®, a patented marine oil lipid and omega-3 PUFA blend derived from the New Zealand green lipped mussel (Perna canaliculus), on indirect markers of muscle damage and inflammation after muscle damaging exercise in untrained men: a randomized, placebo controlled trial.
Mickleborough TD; Sinex JA; Platt D; Chapman RF; Hirt M
J Int Soc Sports Nutr; 2015; 12():10. PubMed ID: 25722660
[TBL] [Abstract][Full Text] [Related]
11. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Gillies D; Leach MJ; Perez Algorta G
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007986. PubMed ID: 37058600
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.
Rheims S; Herbillon V; Gaillard S; Mercier C; Villeuve N; Villéga F; Cances C; Castelnau P; Napuri S; de Saint-Martin A; Auvin S; Nguyen The Tich S; Berquin P; de Bellecize J; Milh M; Roy P; Arzimanoglou A; Bodennec J; Bezin L; Kassai B;
Epilepsia Open; 2024 Apr; 9(2):582-591. PubMed ID: 38173190
[TBL] [Abstract][Full Text] [Related]
13. Perna canaliculus lipid complex PCSO-524™ demonstrated pain relief for osteoarthritis patients benchmarked against fish oil, a randomized trial, without placebo control.
Zawadzki M; Janosch C; Szechinski J
Mar Drugs; 2013 Jun; 11(6):1920-35. PubMed ID: 23739042
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.
Matsudaira T; Gow RV; Kelly J; Murphy C; Potts L; Sumich A; Ghebremeskel K; Crawford MA; Taylor E
J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):775-82. PubMed ID: 26682998
[TBL] [Abstract][Full Text] [Related]
15. Marine lipids: overview "news insights and lipid composition of Lyprinol".
Sinclair AJ; Murphy KJ; Li D
Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.
Cornu C; Mercier C; Ginhoux T; Masson S; Mouchet J; Nony P; Kassai B; Laudy V; Berquin P; Franc N; Le Heuzey MF; Desombre H; Revol O
Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):377-384. PubMed ID: 28993963
[TBL] [Abstract][Full Text] [Related]
17. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
18. ω-3 and ω-6 Fatty Acid Supplementation May Reduce Autism Symptoms Based on Parent Report in Preterm Toddlers.
Keim SA; Gracious B; Boone KM; Klebanoff MA; Rogers LK; Rausch J; Coury DL; Sheppard KW; Husk J; Rhoda DA
J Nutr; 2018 Feb; 148(2):227-235. PubMed ID: 29490101
[TBL] [Abstract][Full Text] [Related]
19. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children.
Schuchardt JP; Huss M; Stauss-Grabo M; Hahn A
Eur J Pediatr; 2010 Feb; 169(2):149-64. PubMed ID: 19672626
[TBL] [Abstract][Full Text] [Related]
20. Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children.
Carucci S; Romaniello R; Demuru G; Curatolo P; Grelloni C; Masi G; Liboni F; Mereu A; Contu P; Lamberti M; Gagliano A; Zuddas A
Eur Arch Psychiatry Clin Neurosci; 2022 Dec; 272(8):1453-1467. PubMed ID: 35672606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
